Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
epinephrine (levophed) (2017)
naloxone (narcan) (2021)
Key: Adamis Pharmaceuticals Corporation (2) Acquired (1)
beclomethasone (vanceril) (2 trials)
monolaurin (1 trial)
tempol (1 trial)
apc-100 (1 trial)
Asthma (Phase 3)
Prostatic Neoplasms (Phase 2)
Trials (5 total)
Trial APIs (4 total)